These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 11901048)

  • 1. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease.
    Zoccali C; Mallamaci F; Parlongo S; Cutrupi S; Benedetto FA; Tripepi G; Bonanno G; Rapisarda F; Fatuzzo P; Seminara G; Cataliotti A; Stancanelli B; Malatino LS
    Circulation; 2002 Mar; 105(11):1354-9. PubMed ID: 11901048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of neuropeptide y as an adverse cardiovascular risk factor in end-stage renal disease.
    Zoccali C; Mallamaci F; Tripepi G; Benedetto FA; Parlongo S; Cutrupi S; Iellamo D; Bonanno G; Rapisarda F; Fatuzzo P; Seminara G; Cataliotti A; Malatino LS
    J Am Soc Nephrol; 2003 Oct; 14(10):2611-7. PubMed ID: 14514739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norepinephrine, left ventricular disorders and volume excess in ESRD.
    Abd ElHafeez S; Tripepi G; Stancanelli B; Dounousi E; Malatino L; Mallamaci F; Zoccali C
    J Nephrol; 2015 Dec; 28(6):729-37. PubMed ID: 25708914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norepinephrine and concentric hypertrophy in patients with end-stage renal disease.
    Zoccali C; Mallamaci F; Tripepi G; Parlongo S; Cutrupi S; Benedetto FA; Cataliotti A; Malatino LS;
    Hypertension; 2002 Jul; 40(1):41-6. PubMed ID: 12105136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenomedullin reflects cardiac dysfunction, excessive blood volume, and inflammation in hemodialysis patients.
    Yoshihara F; Horio T; Nakamura S; Yoshii M; Ogata C; Nakahama H; Inenaga T; Kangawa K; Kawano Y
    Kidney Int; 2005 Sep; 68(3):1355-63. PubMed ID: 16105071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients.
    Mallamaci F; Zoccali C; Parlongo S; Tripepi G; Benedetto FA; Cutrupi S; Bonanno G; Fatuzzo P; Rapisarda F; Seminara G; Stancanelli B; Bellanuova I; Cataliotti A; Malatino LS
    Am J Kidney Dis; 2002 Jul; 40(1):68-75. PubMed ID: 12087563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease.
    Mallamaci F; Tripepi G; Maas R; Malatino L; Böger R; Zoccali C
    J Am Soc Nephrol; 2004 Feb; 15(2):435-41. PubMed ID: 14747391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression.
    Zoccali C; Benedetto FA; Mallamaci F; Tripepi G; Giacone G; Stancanelli B; Cataliotti A; Malatino LS
    Kidney Int; 2004 Apr; 65(4):1492-8. PubMed ID: 15086493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients.
    Mallamaci F; Zoccali C; Tripepi G; Fermo I; Benedetto FA; Cataliotti A; Bellanuova I; Malatino LS; Soldarini A;
    Kidney Int; 2002 Feb; 61(2):609-14. PubMed ID: 11849403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of aortic stiffness on survival in end-stage renal disease.
    Blacher J; Guerin AP; Pannier B; Marchais SJ; Safar ME; London GM
    Circulation; 1999 May; 99(18):2434-9. PubMed ID: 10318666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-recovery from dialysis-requiring acute kidney injury and short-term mortality and cardiovascular risk: a cohort study.
    Lee BJ; Hsu CY; Parikh RV; Leong TK; Tan TC; Walia S; Liu KD; Hsu RK; Go AS
    BMC Nephrol; 2018 Jun; 19(1):134. PubMed ID: 29890946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic role of brain natriuretic peptides in hemodialysis patients.
    Naganuma T; Sugimura K; Wada S; Yasumoto R; Sugimura T; Masuda C; Uchida J; Nakatani T
    Am J Nephrol; 2002; 22(5-6):437-44. PubMed ID: 12381941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease.
    Apple FS; Murakami MM; Pearce LA; Herzog CA
    Circulation; 2002 Dec; 106(23):2941-5. PubMed ID: 12460876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in neurohormonal activity partially explain the obesity paradox in patients with heart failure: The role of sympathetic activation.
    Farré N; Aranyó J; Enjuanes C; Verdú-Rotellar JM; Ruiz S; Gonzalez-Robledo G; Meroño O; de Ramon M; Moliner P; Bruguera J; Comin-Colet J
    Int J Cardiol; 2015 Feb; 181():120-6. PubMed ID: 25497534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dental Health and Mortality in People With End-Stage Kidney Disease Treated With Hemodialysis: A Multinational Cohort Study.
    Palmer SC; Ruospo M; Wong G; Craig JC; Petruzzi M; De Benedittis M; Ford P; Johnson DW; Tonelli M; Natale P; Saglimbene V; Pellegrini F; Celia E; Gelfman R; Leal MR; Torok M; Stroumza P; Bednarek-Skublewska A; Dulawa J; Frantzen L; Ferrari JN; Del Castillo D; Bernat AG; Hegbrant J; Wollheim C; Gargano L; Bots CP; Strippoli GF;
    Am J Kidney Dis; 2015 Oct; 66(4):666-76. PubMed ID: 26120038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure.
    Zoccali C; Mallamaci F; Tripepi G; Cutrupi S; Parlongo S; Malatino LS; Bonanno G; Rapisarda F; Fatuzzo P; Seminara G; Stancanelli B; Nicocia G; Buemi M
    J Intern Med; 2003 Aug; 254(2):132-9. PubMed ID: 12859694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
    Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low triiodothyronine and survival in end-stage renal disease.
    Zoccali C; Mallamaci F; Tripepi G; Cutrupi S; Pizzini P
    Kidney Int; 2006 Aug; 70(3):523-8. PubMed ID: 16775599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis.
    Tozawa M; Iseki K; Iseki C; Takishita S
    Kidney Int; 2002 Feb; 61(2):717-26. PubMed ID: 11849415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma norepinephrine is an independent predictor of adverse cerebral and cardiovascular events in type 2 diabetic patients without structural heart disease.
    Yufu K; Okada N; Ebata Y; Murozono Y; Shinohara T; Nakagawa M; Takahashi N
    J Cardiol; 2014 Sep; 64(3):225-30. PubMed ID: 24529506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.